Afatinib for lung cancer: let there be light?
- PMID: 24439930
- DOI: 10.1016/S1470-2045(14)70002-6
Afatinib for lung cancer: let there be light?
Erratum in
- Lancet Oncol. 2014 Mar;15(3):e106
Comment on
-
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.Lancet Oncol. 2014 Feb;15(2):213-22. doi: 10.1016/S1470-2045(13)70604-1. Epub 2014 Jan 15. Lancet Oncol. 2014. PMID: 24439929 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
